Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands
Book Now
Menu
Book

Lucas Bethge, Ph.D.
VP, Group Leader Chemistry at Silence Therapeutics
Speaker

Profile

Lucas Bethge studied chemistry at the Humboldt-University zu Berlin (Germany). After he obtained his Ph.D. in 2011 in Bioorganic Chemistry, he first joined NOXXON Pharma. In 2016 he moved to Silence Therapeutics GmbH, a biotech company in Berlin that develops GalNAc-conjugated siRNA for therapeutic use. Currently, he is Vice-President and leading the Oligonucleotide Chemistry group at Silence Therapeutics. Lucas is an expert for the synthesis, conjugation and analysis of oligonucleotides with over ten years of experience in industrial research and development at the interface between early research and clinical development.

Agenda Sessions

  • Elongating siRNA Duration of Action by Enhanced Nuclease Resistance: End Stabilization Revisited

    , 10:15
    View Session

At this event

Prev
Next
Dr. Sergey Tsukanov, PhD
Senior Director Chemistry
Eli Lilly and Company

See Lucas at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now